HERMES Publication

Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study

Mendelian randomization of body mass index with clinical outcomes and mortality in patients with heart failure, by LVEF subgroup

GWASHub: An Automated Cloud-Based Platform for Genome-Wide Association Study Meta-Analysis

GWASHub: an automated cloud-based platform for quality control and meta-analysis of large GWAS consortia (preprint)

Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes

HERMES GWAS meta-analysis of heart failure and its subtypes in 1.9 million individuals, identifying 66 loci (37 novel)

Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy

GWAS and multi-trait analysis of dilated cardiomyopathy (14,256 cases) identifying 80 risk loci and 62 putative effector genes

Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization

Proteomics and Mendelian randomization of 90 cardiovascular proteins identify candidate drug targets for heart failure

The genomics of heart failure: design and rationale of the HERMES consortium

Design and rationale of the HERMES Consortium for the genomics of heart failure

Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study

Mendelian randomization of type 2 diabetes, insulin resistance and glycaemic traits with risk of heart failure